Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
-
Industry
-
Milestones
- Lux investment: 2016
-
Founders
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
LUX Partners
-
Latest Tweets
- Today, we announced the appointment of Dr. Ramona Doyle as our Chief Medical Officer. Dr. Doyle will lead our pipel… https://t.co/HUpK1lFzJy
- We’re honored to partner with @MenloVentures to donate 10k to the @4thStreetClinic, which provides health care and… https://t.co/XdyA3d5zcU
- Our #PeopleOps team is growing! We're hiring a Sr. Business People Partner to help us in accelerating an environmen… https://t.co/yjNsyKhNkU